@article{59a60830f75f11ddbf70000ea68e967b,
title = "Antithrombin III for critically ill patients",
abstract = "Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown.",
author = "Arash Afshari and J{\o}rn Wetterslev and Brok, {Jesper Sune} and M{\o}ller, {Ann Merete}",
note = "Times Cited: 0ReviewEnglishAfshari, AUniv Copenhagen, Rigshosp, Dept Paediat & Obstet Anaesthesiol, Blegdamsvej 9, DK-2100 Copenhagen O, DenmarkCited References Count: 87328PSJOHN WILEY & SONS LTDTHE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLANDCHICHESTER",
year = "2008",
month = jan,
day = "1",
doi = "10.1002/14651858.CD005370.pub2",
language = "English",
pages = "CD005370",
journal = "Cochrane Database of Systematic Reviews",
issn = "1361-6137",
publisher = "Wiley",
number = "3",
}